Huajian Medical and Renhe International reach cooperation to jointly build a vertical RWA trading platform focused on the over-the-counter drug sector
Jinse Finance reported that Huajian Medical, a Hong Kong-listed company, has issued an announcement stating that the group has reached a strategic cooperation with Renhe International, a wholly-owned subsidiary of Renhe Pharmaceutical Co., Ltd. Together, they will jointly establish a vertical RWA trading platform in the United States focused on the over-the-counter drug sector. (Zhitong Finance)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
SOL treasury companies and ETF total holdings exceed 24.2 million SOL, equivalent to approximately $3.44 billions
Institutions increased their BTC holdings by over $500 million in the past 30 days
Adam Back: Strategy's leverage ratio is very low, previously only transferred BTC to another custodian and did not sell
Trending news
MoreCrypto prices
More
